Objective Macular Asymmetry Metrics for Glaucoma Detection Using a Temporal Raphe–Based OCT Linearization Algorithm

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background/Objectives: We aim to develop an image linearization process and a program capable of quantifying vertical and left–right asymmetries observed in macular scans. We then sought to verify its applicability in clinical settings. Methods: In this single-center cross-sectional study, we examined 37 consecutive patients with unilateral open-angle glaucoma and analyzed paired data (glaucomatous eye vs. fellow normal eye). Spectral-domain OCT images were automatically processed by a custom program to align the disc–fovea axis and temporal raphe, and the following parameters were evaluated: (1) mean inner retinal thickness difference (superior–inferior), (2) Vertical Asymmetry Score, and (3) Quadrantal Asymmetry Score. Results: We analyzed 37 healthy eyes and 37 POAG eyes. After linearization, the mean inner retinal thicknesses for the normal and POAG groups were 93.4 µm (interquartile range [IQR]: 90.1–98.5) and 80.3 µm (IQR: 77.3–85.0), respectively. The Vertical Asymmetry Score was 6.80 (IQR: 6.15–7.25) for healthy eyes and 9.69 (IQR: 9.16–11.58) for POAG eyes. The Quadrantal Asymmetry Score was 6.35 (IQR: 5.94–7.19) for healthy eyes and 8.47 (IQR: 8.11–9.63) for POAG eyes. Significant differences were found between groups for all parameters (p < 0.001). The Vertical Asymmetry Score (AUC = 0.967, p < 0.001) and Quadrantal Asymmetry Score (AUC = 0.946, p < 0.001) demonstrated significantly greater accuracy in detecting glaucoma compared to the mean inner retinal thickness (AUC = 0.743). Conclusions: The developed linearization program and asymmetry scores have shown promise as parameters for objectively quantifying macular asymmetry using spectral-domain OCT. External validation in independent cohorts, including bilateral disease, is warranted.

Article activity feed